There’s a shocking lack of understanding of the physics underlying this commonplace phenomenon, but researchers are on the ...
This article introduces practical methods for evaluating AI agents operating in real-world environments. It explains how to ...
During a live event, Nataliya Mar, MD, discussed systemic therapies such as lenvatinib/pembrolizumab in advanced renal cell carcinoma based on recent trials. Renal cell carcinoma (RCC) treatment has ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Packaged as part of the 2018 version 10 release, the Java var reserved word introduced type ...
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
Dr Jonathan Goldman, of the University of California, Los Angeles, shares key updates in metastatic non-small cell lung cancer from ASCO 2025. Dr Goldman reviews findings from TROPION-Lung02, which ...
Healthier lifestyles were associated with improved overall survival but not prostate cancer–specific survival in a multiethnic cohort of patients with nonmetastatic prostate cancer. Behavioral scores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results